Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Snider

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Neuropsychobiology|January 1, 1977
Detection of presymptomatic carriers of Huntington's choreaS Rosenberg, E Metzig, S R Snider, et al.
The New England Journal of Medicine|July 24, 1975
Letter: Pain, paresthesia and parkinsonismS R Snider, S Fahn, L J Cote, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further experiences with low doses of bromocriptine in Parkinson's diseaseS Fahn, L J Côté, R E Barrett, et al.
Life Sciences|July 1, 1985
Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's diseaseT C Case, S R Snider, V J Hruby, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.
Advances in Neurology|January 1, 1983
Pergolide treatment in parkinsonismJ Ilson, S Fahn, R Mayeux, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.
Physiology & Behavior|February 1, 1971
Physical dependence on and tolerance to alcohol in the ratT J Cicero, S R Snider, V J Perez, et al.
Acta Physiologica Scandinavica|April 1, 1974
Effect of ischemia on monoamine metabolism in the brainR M Brown, A Carlson, B Ljunggren, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Neuropsychobiology|January 1, 1977
Detection of presymptomatic carriers of Huntington's choreaS Rosenberg, E Metzig, S R Snider, et al.
The New England Journal of Medicine|July 24, 1975
Letter: Pain, paresthesia and parkinsonismS R Snider, S Fahn, L J Cote, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further experiences with low doses of bromocriptine in Parkinson's diseaseS Fahn, L J Côté, R E Barrett, et al.
Life Sciences|July 1, 1985
Active and inactive L-prolyl-L-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's diseaseT C Case, S R Snider, V J Hruby, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.
Advances in Neurology|January 1, 1983
Pergolide treatment in parkinsonismJ Ilson, S Fahn, R Mayeux, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.
Physiology & Behavior|February 1, 1971
Physical dependence on and tolerance to alcohol in the ratT J Cicero, S R Snider, V J Perez, et al.
Acta Physiologica Scandinavica|April 1, 1974
Effect of ischemia on monoamine metabolism in the brainR M Brown, A Carlson, B Ljunggren, et al.
Pageof 8